Huang Donghui, Wu Qijun, Xu Xin, Ji Chao, Xia Yang, Zhao Zhiying, Dai Huixu, Li Hang, Gao Shanyan, Chang Qing, Zhao Yuhong
Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China.
Clinical Research Center, Shengjing Hospital of China Medical University, Shenyang, China.
Front Nutr. 2022 Jun 9;9:900529. doi: 10.3389/fnut.2022.900529. eCollection 2022.
This study aimed to systematically review current evidence and quantitatively evaluate the associations between milk or dairy consumption during pregnancy and birth outcomes.
This systematic review had been reported in accordance with the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. A supplementary literature search in PubMed, Web of Science, Cochrane Library, and Embase was conducted on 30 March 2021. Studies that assessed the association of maternal consumption of milk or dairy with birth-related outcomes were identified. The dose-response meta-analyses of continuous data and categorical data were applied. One-stage approach and two-stage approach were used where appropriate.
In total, 42 studies were eligible for the present systematic review, and 18 of them were included in the outcome-specific meta-analyses. The dose-response meta-analysis [Number of studies () = 9] predicted a maximum mean change in birthweight of 63.38 g [95% Confidence Interval (CI) = 0.08, 126.67] at 5.00 servings per day. Intake of dairy products had the greatest protective effect on small for gestational age at a maximum of 7.2 servings per day [Relative risk (RR) = 0.69, 95% CI = 0.56, 0.85] ( = 7). The risk of large for gestational age was predicted to be maximum at 7.20 servings per day of dairy consumption, with the RR and 95% CI of 1.30 (1.15, 1.46; = 4). In addition, the relationship between dairy consumption and low birth weight (RR = 0.70, 95% CI = 0.33, 1.50; = 5) and pre-mature birth (RR = 1.13, 95% CI = 0.87, 1.47; = 5) was not significant, respectively.
Maternal consumption of dairy during pregnancy has a potential effect on fetal growth. Further well-designed studies are warranted to clarify the specific roles of individual dairy products.
identifier: PROSPERO 2020 CRD42020150608.
本研究旨在系统回顾当前证据,并定量评估孕期牛奶或乳制品摄入量与分娩结局之间的关联。
本系统评价按照系统评价和Meta分析的首选报告项目(PRISMA)声明的指南进行报告。于2021年3月30日在PubMed、科学网、Cochrane图书馆和Embase中进行了补充文献检索。纳入评估母亲牛奶或乳制品摄入量与分娩相关结局之间关联的研究。应用了连续数据和分类数据的剂量反应Meta分析。在适当情况下采用单阶段法和两阶段法。
共有42项研究符合本系统评价的纳入标准,其中18项纳入了特定结局的Meta分析。剂量反应Meta分析(研究数量(n)=9)预测,每天摄入5.00份时,出生体重的最大平均变化为63.38克[95%置信区间(CI)=0.08,126.67]。每天最多摄入7.2份乳制品时,对小于胎龄儿的保护作用最大[相对危险度(RR)=0.69,95%CI=0.56,0.85]((n)=7)。预测每天摄入7.20份乳制品时,大于胎龄儿的风险最大,RR和95%CI为1.30(1.15,1.46;(n)=4)。此外,乳制品摄入量与低出生体重(RR=0.70,95%CI=0.33,1.50;(n)=5)和早产(RR=1.13,95%CI=0.87,1.47;(n)=5)之间的关系均不显著。
孕期母亲食用乳制品对胎儿生长有潜在影响。需要进一步开展设计良好的研究以阐明单个乳制品的具体作用。
标识符:PROSPERO 2020 CRD42020150608。